The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 16, 2021

Filed:

Oct. 30, 2017
Applicant:

Eyegene Inc., Seoul, KR;

Inventors:

Yang Je Cho, Seoul, KR;

Kwangsung Kim, Gyeonggi-do, KR;

Na Gyong Lee, Seoul, KR;

Shin Ae Park, Seoul, KR;

Assignee:

EYEGENE INC., Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61P 31/12 (2006.01); A61K 39/39 (2006.01); C08B 37/00 (2006.01); A61K 31/739 (2006.01); A61K 39/002 (2006.01); A61K 39/00 (2006.01); A61K 39/295 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 31/739 (2013.01); A61K 39/00 (2013.01); A61K 39/002 (2013.01); A61K 39/295 (2013.01); A61K 39/39 (2013.01); A61P 31/12 (2018.01); C08B 37/006 (2013.01); A61K 2039/522 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/6087 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention relates to an immune modulator having a novel structure, and an immunologic adjuvant composition containing the same and, more specifically, to an modulator, which is a lipopolysaccharide (LPS) analog having reduced toxicity, and a use thereof. The immune modulator of the present invention exhibits immune enhancement effects by having excellent innate immunity and ability to induce an adaptive immune response to a specific pathogen, and is very safe by having low toxicity. In addition, a vaccine containing the immune modulator of the present invention contains both an immune modulator and an alum, thereby improving immune enhancement effects compared with when using only the immune modulator.


Find Patent Forward Citations

Loading…